Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Glaucoma, Open-angle, Ocular Hypertension (OHT), Phacoemulsification Cataract Surgery

In brief

This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone

Key facts

Study ID

NCT06848946

Run by

Glaukos Corporation

People needed

132

Starts

2025-01-13

Expected to finish

2027-06-01

Last updated by the study team

2026-01-21

Who can join

Age: 45 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cataract diagnosis: clinically significant age-related cataract eligible for phacoemulsification in the study eye.
• OAG or OHT diagnosis: either OAG (i.e. primary, pseudoexfoliation, or pigmentary glaucoma) or OHT in the study eye (i.e., eye to undergo cataract surgery)

You may not qualify if…

• Active corneal inflammation or edema.
• Retinal disorders not associated with glaucoma.

Where it is running

• Glaukos Investigator Site — Kenosha, Wisconsin, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.